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background:  Sinus of Valsalva aneurysm (SVA) is a rare anomaly and is mostly congenital. It can rupture into one of the cardiac 
chambers leading to aorto-cardiac fistula. Urgent repair is recommended to prevent heart failure. Surgical repair with patch closure 
has been the treatment of choice. Percutaneous closure is a newer, less invasive alternative to open surgery. We wanted to determine 
the success rate and mortality of percutaneous closure of ruptured sinus of Valsalva aneurysm (RSVA) and to identify the potential 
complications of the procedure.
methods:  A systematic search of Pubmed and Cochrane library were conducted. Key words used in the search were “percutaneous 
closure” and “ruptured sinus of Valsalva aneurysm”. Case reports and case series published in English involving patients above the age of 
16 years were collected and compiled.
results:  The mean age of the patients undergoing percutaneous closure for RSVA was 35.2 years (Range 16-74). Most of the aneurysms 
originated from the right coronary sinus (59%). The most common site of rupture was the right atrium (57%) followed by the right ventricle 
(40%). Shortness of breath was the commonest symptoms at presentation. Most of the operators (80%) preferred to use a PDA occluder 
to close the ruptured aneurysmal tract. The occluders were successfully deployed in 96% (142/148) patients. Of the people in whom the 
devices were successfully deployed, 15% (21/142) had complications, most of which were managed medically. Almost all of the patients 
who underwent a successful procedure had improvement in their symptoms.
Conclusion:  Percutaneous closure of RSVA is an alternative to open surgical repair with a good success rate. RSVA with multiple fistulae 
or concomitant VSD or ASD can also be managed successfully via percutaneous approach. Patients had significant decreased duration of 
hospital stay, lower medical expenditure, decreased need for ICU placement and blood transfusions. Successful intervention has also been 
shown to decrease the enlarged cardiac chamber size and improve cardiac function. Patients should be followed up with echocardiography 
and monitored for any residual shunt, recurrence, thromboembolism or aortic regurgitation.
